BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 23424091)

  • 1. Cerebral amyloid angiopathy burden associated with leukoaraiosis: a positron emission tomography/magnetic resonance imaging study.
    Gurol ME; Viswanathan A; Gidicsin C; Hedden T; Martinez-Ramirez S; Dumas A; Vashkevich A; Ayres AM; Auriel E; van Etten E; Becker A; Carmasin J; Schwab K; Rosand J; Johnson KA; Greenberg SM
    Ann Neurol; 2013 Apr; 73(4):529-36. PubMed ID: 23424091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of cerebral microbleeds: In vivo imaging of amyloid and subcortical ischemic small vessel disease in 226 individuals with cognitive impairment.
    Park JH; Seo SW; Kim C; Kim GH; Noh HJ; Kim ST; Kwak KC; Yoon U; Lee JM; Lee JW; Shin JS; Kim CH; Noh Y; Cho H; Kim HJ; Yoon CW; Oh SJ; Kim JS; Choe YS; Lee KH; Lee JH; Ewers M; Weiner MW; Werring DJ; Na DL
    Ann Neurol; 2013 May; 73(5):584-93. PubMed ID: 23495089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging of amyloid burden and distribution in cerebral amyloid angiopathy.
    Johnson KA; Gregas M; Becker JA; Kinnecom C; Salat DH; Moran EK; Smith EE; Rosand J; Rentz DM; Klunk WE; Mathis CA; Price JC; Dekosky ST; Fischman AJ; Greenberg SM
    Ann Neurol; 2007 Sep; 62(3):229-34. PubMed ID: 17683091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI-visible perivascular space location is associated with Alzheimer's disease independently of amyloid burden.
    Banerjee G; Kim HJ; Fox Z; Jäger HR; Wilson D; Charidimou A; Na HK; Na DL; Seo SW; Werring DJ
    Brain; 2017 Apr; 140(4):1107-1116. PubMed ID: 28335021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Florbetapir Regional Distribution in Cerebral Amyloid Angiopathy and Alzheimer's Disease: A PET Study.
    Planton M; Saint-Aubert L; Raposo N; Payoux P; Salabert AS; Albucher JF; Olivot JM; Péran P; Pariente J
    J Alzheimers Dis; 2020; 73(4):1607-1614. PubMed ID: 31958082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of vascular amyloid on white matter disease is mediated by vascular dysfunction in cerebral amyloid angiopathy.
    Gokcal E; Horn MJ; Becker JA; Das AS; Schwab K; Biffi A; Rost N; Rosand J; Viswanathan A; Polimeni JR; Johnson KA; Greenberg SM; Gurol ME
    J Cereb Blood Flow Metab; 2022 Jul; 42(7):1272-1281. PubMed ID: 35086372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral Amyloid Angiopathy Pathology and Its Association With Amyloid-β PET Signal.
    McCarter SJ; Lesnick TG; Lowe V; Mielke MM; Constantopoulos E; Rabinstein AA; Przybelski SA; Botha H; Jones DT; Ramanan VK; Jack CR; Petersen RC; Knopman D; Boeve BF; Murray ME; Dickson DW; Vemuri P; Kantarci K; Reichard RR; Graff-Radford J
    Neurology; 2021 Nov; 97(18):e1799-e1808. PubMed ID: 34504022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatial relation between microbleeds and amyloid deposits in amyloid angiopathy.
    Dierksen GA; Skehan ME; Khan MA; Jeng J; Nandigam RN; Becker JA; Kumar A; Neal KL; Betensky RA; Frosch MP; Rosand J; Johnson KA; Viswanathan A; Salat DH; Greenberg SM
    Ann Neurol; 2010 Oct; 68(4):545-8. PubMed ID: 20865701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Utility of Integrated
    Chang Y; Liu J; Wang L; Li X; Wang Z; Lin M; Jin W; Zhu M; Xu B
    Front Aging Neurosci; 2021; 13():721780. PubMed ID: 34899265
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnostic utility of amyloid PET in cerebral amyloid angiopathy-related symptomatic intracerebral hemorrhage.
    Baron JC; Farid K; Dolan E; Turc G; Marrapu ST; O'Brien E; Aigbirhio FI; Fryer TD; Menon DK; Warburton EA; Hong YT
    J Cereb Blood Flow Metab; 2014 May; 34(5):753-8. PubMed ID: 24619277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral microhemorrhage and brain β-amyloid in aging and Alzheimer disease.
    Yates PA; Sirisriro R; Villemagne VL; Farquharson S; Masters CL; Rowe CC;
    Neurology; 2011 Jul; 77(1):48-54. PubMed ID: 21700585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. White matter hyperintensities are associated with amyloid burden in APOE4 non-carriers.
    Noh Y; Seo SW; Jeon S; Lee JM; Kim JH; Kim GH; Cho H; Yoon CW; Kim HJ; Ye BS; Kim ST; Choe YS; Lee KH; Kim JS; Ewers M; Weiner MW; Lee JH; Werring DJ; Kang DR; Kim CS; Na DL
    J Alzheimers Dis; 2014; 40(4):877-86. PubMed ID: 24577457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease?
    Provenzano FA; Muraskin J; Tosto G; Narkhede A; Wasserman BT; Griffith EY; Guzman VA; Meier IB; Zimmerman ME; Brickman AM;
    JAMA Neurol; 2013 Apr; 70(4):455-61. PubMed ID: 23420027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silent ischemic infarcts are associated with hemorrhage burden in cerebral amyloid angiopathy.
    Kimberly WT; Gilson A; Rost NS; Rosand J; Viswanathan A; Smith EE; Greenberg SM
    Neurology; 2009 Apr; 72(14):1230-5. PubMed ID: 19349602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal Fluid, MRI, and Florbetaben-PET in Cerebral Amyloid Angiopathy-Related Inflammation.
    Renard D; Collombier L; Demattei C; Wacongne A; Charif M; Ayrignac X; Azakri S; Gaillard N; Boudousq V; Lehmann S; Menjot de Champfleur N; Thouvenot E
    J Alzheimers Dis; 2018; 61(3):1107-1117. PubMed ID: 29254099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging features of small vessel disease in cerebral amyloid angiopathy among patients with Alzheimer's disease.
    Nagaraja N; DeKosky S; Duara R; Kong L; Wang WE; Vaillancourt D; Albayram M
    Neuroimage Clin; 2023; 38():103437. PubMed ID: 37245492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of White Matter Abnormalities in the Relationship Between Microbleed Burden and Cognitive Impairment in Cerebral Amyloid Angiopathy.
    Jo S; Cheong EN; Kim N; Oh JS; Shim WH; Kim HJ; Lee SJ; Lee Y; Oh M; Kim JS; Kim BJ; Roh JH; Kim SJ; Lee JH
    J Alzheimers Dis; 2022; 86(2):667-678. PubMed ID: 35124637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of amyloid β positivity in patients with probable cerebral amyloid angiopathy markers.
    Jang H; Jang YK; Kim HJ; Werring DJ; Lee JS; Choe YS; Park S; Lee J; Kim KW; Kim Y; Cho SH; Kim SE; Kim SJ; Charidimou A; Na DL; Seo SW
    Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1287-1298. PubMed ID: 30937462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood viscosity in subcortical vascular mild cognitive impairment with versus without cerebral amyloid burden.
    Noh HJ; Seo SW; Jeong Y; Park JE; Kim GH; Noh Y; Cho H; Kim HJ; Yoon CW; Ye BS; Werring DJ; Na DL
    J Stroke Cerebrovasc Dis; 2014; 23(5):958-66. PubMed ID: 24589034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of APOE ε4 on brain amyloid, lacunar infarcts, and white matter lesions: a study among patients with subcortical vascular cognitive impairment.
    Kim HJ; Ye BS; Yoon CW; Cho H; Noh Y; Kim GH; Choi YS; Kim JH; Jeon S; Lee JM; Kim JS; Choe YS; Lee KH; Kim ST; Kim C; Kang DR; Ki CS; Lee JH; Werring DJ; Weiner MW; Na DL; Seo SW
    Neurobiol Aging; 2013 Nov; 34(11):2482-7. PubMed ID: 23769398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.